Kunogi Hiroaki, Yamaguchi Nanae, Terao Yasuhisa, Sasai Keisuke
Department of Radiation Oncology, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Department of Gynecology, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
PLoS One. 2016 Jun 3;11(6):e0156623. doi: 10.1371/journal.pone.0156623. eCollection 2016.
Coplanar extended-field intensity-modulated radiation therapy (EF-IMRT) targeting the whole-pelvic and para-aortic lymph nodes in patients with advanced cervical cancer results in impaired creatinine clearance. An improvement in renal function cannot be expected unless low-dose (approximately 10 Gy) kidney exposure is reduced. The dosimetric method should be considered during EF-IMRT planning to further reduce low-dose exposure to the kidneys. To assess the usefulness of non-coplanar EF-IMRT with kidney-avoiding beams to spare the kidneys during cervical carcinoma treatment in dosimetric analysis between non-coplanar and coplanar EF-IMRT, we compared the doses of the target organ and organs at risk, including the kidney, in 10 consecutive patients. To estimate the influence of EFRT on renal dysfunction, creatinine clearance values after treatment were also examined in 18 consecutive patients. Of these 18 patients, 10 patients who were included in the dosimetric analysis underwent extended field radiation therapy (EFRT) with concurrent chemotherapy, and eight patients underwent whole-pelvis radiation therapy with concurrent chemotherapy to treat cervical carcinoma between April 2012 and March 2015 at our institution. In the dosimetric analysis, non-coplanar EF-IMRT was effective at reducing low-dose (approximately 10 Gy) exposure to the kidneys, thus maintaining target coverage and sparing other organs at risk, such as the small bowel, rectum, and bladder, compared with coplanar EF-IMRT. Renal function in all 10 patients who underwent EFRT, including coplanar EF-IMRT (with kidney irradiation), was low after treatment, and differed significantly from that of the eight patients who underwent WPRT (no kidney irradiation) 6 months after the first day of treatment (P = 0.005). In conclusion, non-coplanar EF-IMRT should be considered in patients with advanced cervical cancer, particularly in patients with a long life expectancy or with pre-existing renal dysfunction.
针对晚期宫颈癌患者的全盆腔和腹主动脉旁淋巴结进行的共面扩展野调强放射治疗(EF-IMRT)会导致肌酐清除率受损。除非减少低剂量(约10 Gy)的肾脏照射,否则肾功能无法得到改善。在EF-IMRT计划期间应考虑剂量测定方法,以进一步减少对肾脏的低剂量照射。为了评估在宫颈癌治疗中使用具有肾脏避让射束的非共面EF-IMRT在剂量分析中对肾脏的保护作用,我们比较了10例连续患者中靶器官和包括肾脏在内的危及器官的剂量。为了评估EFRT对肾功能障碍的影响,我们还检查了18例连续患者治疗后的肌酐清除率值。在这18例患者中,2012年4月至2015年3月在我们机构,10例纳入剂量分析的患者接受了扩展野放射治疗(EFRT)并同步化疗,8例患者接受了全盆腔放射治疗并同步化疗以治疗宫颈癌。在剂量分析中,与共面EF-IMRT相比,非共面EF-IMRT在减少低剂量(约10 Gy)肾脏照射方面有效,从而维持靶区覆盖并保护其他危及器官,如小肠、直肠和膀胱。所有接受EFRT的10例患者,包括共面EF-IMRT(有肾脏照射),治疗后肾功能均较低,与8例接受全盆腔放射治疗(无肾脏照射)的患者在治疗第一天后6个月时的肾功能有显著差异(P = 0.005)。总之,对于晚期宫颈癌患者,尤其是预期寿命较长或已有肾功能不全的患者,应考虑使用非共面EF-IMRT。